US Patent Issued to KIM CELL & GENE on Sept. 29 for "Recombinant vector comprising codon-optimized TIF1Gamma polynucleotide, and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,274, issued on Sept. 29, was assigned to KIM CELL & GENE Co. LTD. (Seoul, South Korea).

"Recombinant vector comprising codon-optimized TIF1Gamma polynucleotide, and use thereof" was invented by Hyo-Soo Kim (Seoul, South Korea) and Eun Ju Lee (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a polynucleotide in which an N-terminal region of TIF1Gamma gene is codon-optimized, a recombinant vector including the polynucleotide, and a use thereof."

The patent was filed on Jan. 14, 2021, under Application No. 17/758,853.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/neta...